A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes

Trial Profile

A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Mar 2015

At a glance

  • Drugs Insulin degludec/insulin aspart (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 29 Jun 2012 Actual end date changed from Jan 2012 to Apr 2012 as reported by ClinicalTrials.gov.
    • 17 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Dec 2011 Planned end date changed from 1 Feb 2012 to 1 Jan 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top